-
Mashup Score: 192AI Voices - NaturalReader Home - 1 year(s) ago
NaturalReader: Free Text to Speech for Online, Mobile App, Commercial license and Education with AI voices.
Source: www.naturalreaders.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 7mcyt. Portal de empleo i+d+i : CONTRATO POSTDOCTORAL JUNIOR. Fundación Investigación Biomédica Hospital La Paz FIBHLP - 1 year(s) ago
Requisitos imprescindibles: -No haber cumplido los 30 años de edad (a fecha de inicio del contrato). -Estar en posesión del título de Doctor en Biología, Química, Bioquímica o similar (o quevaya a leer la tesis en el próximo mes). -Encontrarse desempleado/a e inscrito/a como demandante de empleo en alguna delas oficinas de empleo de la Comunidad de Madrid. -No haber desempeñado ningún puesto en…
Source: mcyt.educa.madrid.orgCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @Cristina_ferp: We are hiring! A great opportunity to work in CAR T and pediatric tumors! Please RT! https://t.co/98FMIjNZmk @IdipazScie…
-
-
Mashup Score: 1EASIX score predicts inferior survival after allogeneic hematopoietic cell transplantation - Bone Marrow Transplantation - 1 year(s) ago
The Endothelial Activation and Stress Index (EASIX) is a prognostic tool that uses common clinical laboratory values and has been shown to predict non-relapse mortality (NRM) and overall survival (OS) at the onset of acute graft-versus-host disease (GVHD) after allogeneic hematopoietic cell transplantation (HCT). We hypothesized that EASIX calculated at different time points pre- and post- HCT…
Source: NatureCategories: Hem/Oncs, Latest HeadlinesTweet-
Finally out our #EASIX paper on #HSCT 👏👏👏 Thanks to my mentor @DrMiguelPerales and all the @MSKCancerCenter team!! 🤗 https://t.co/GZuvh4MAYM
-
-
Mashup Score: 23Cuaderno_2022_MEDICINA_I.pdf - 1 year(s) agoSource: Google DocsCategories: Hem/Oncs, Latest HeadlinesTweet
-
RT @mirasturias: Aquí tienes el Cuaderno de Examen y el de imágenes del Examen MIR 2022/23. Cuaderno examen : https://t.co/59uUKsQ4iS Cuad…
-
-
Mashup Score: 5Toxicity and efficacy of CAR T-cell therapy in primary and secondary CNS lymphoma: a meta-analysis of 128 patients - 1 year(s) ago
Abstract. Relapsed/refractory primary central nervous system lymphoma (PCNSL) and secondary central nervous system lymphoma (SCNSL) are associated with short su
Source: American Society of HematologyCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @chadinabhan: Efficacy of #CART in primary and secondary CNS lymphoma. reported in @BloodAdvances https://t.co/48tCiHlJrr
-
-
Mashup Score: 4
Venetoclax (VEN) combined with azacitidine (AZA) or decitabine (DEC) has been approved for older adults with acute myeloid leukemia (AML) unfit for intensive chemotherapy based on the pivotal VIALE-A trial. However, this trial only compared AZA + VEN with AZA monotherapy. Therefore, we compared the outcomes of consecutive older adults (65 years or older) with newly diagnosed AML who received DEC…
Source: NatureCategories: Hematologists1, Latest HeadlinesTweet-
RT @smbenlazar: Venetoclax with decitabine versus decitabine monotherapy in elderly acute myeloid leukemia https://t.co/v5OU4Pxgik #leusm #…
-
-
Mashup Score: 2
Diffuse large B-cell lymphoma, the most common subtype of non-Hodgkin lymphoma, comprises a heterogenous group of morphologically, genetically, and clinically distinct diseases. Several recent advances have affected the treatment landscape, which had been mostly stagnant for the past few decades. We will review the practice-changing studies in frontline (POLARIX), early relapse (ZUMA-7 and…
Source: Journal of Clinical OncologyCategories: Hematologists1, Latest HeadlinesTweet-
RT @smbenlazar: Navigating the Evolving Treatment Landscape of Diffuse Large B-Cell Lymphoma https://t.co/QzGrwz8v80 #DLBCL #lysm https://t…
-
-
Mashup Score: 15Management of patients with lower-risk myelodysplastic syndromes - Blood Cancer Journal - 1 year(s) ago
Myelodysplastic syndromes (MDS) are a heterogeneous group of hematopoietic stem cell disorders characterized by ineffective hematopoiesis with abnormal blood cell development (dysplasia) leading to cytopenias and an increased risk for progression to acute myeloid leukemia (AML). Patients with MDS can generally be classified as lower- (LR-MDS) or higher-risk (HR-MDS). As treatment goals for…
Source: NatureCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @smbenlazar: Management of patients with lower-risk myelodysplastic syndromes https://t.co/nTtwzDEiju #MDS https://t.co/07lPUaANEs
-
-
Mashup Score: 3The Expanding Clinical Role of Bifunctional Antibodies | NEJM - 1 year(s) ago
Editorial from The New England Journal of Medicine — The Expanding Clinical Role of Bifunctional Antibodies
Source: New England Journal of MedicineCategories: Hematologists1, Latest HeadlinesTweet-
RT @DrMiguelPerales: The Expanding Clinical Role of Bifunctional Antibodies #ASH22 @NEJM https://t.co/SSU7ctqWKI
-
-
Mashup Score: 5German Lymphoma Alliance - 1 year(s) ago
Sie erreichen die GLA e.V. unter: GLA-Geschäftsstelle c/o DGHO Service GmbH Frau Steffi Heinecke Bauhofstr. 12 10117 Berlin office(a)german-lymphoma-alliance.de Fon: +49(30) 2787 6089-89 (Mitgliedschaft, Termine, Organisatorisches, Studienanfragen) Alle anderen Fragen richten Sie bitte direkt an den Vorstand der GLA unter president(a)german-lymphoma-alliance.de Wir bitten…
Source: scoresCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @DrMiguelPerales: #ASH22 CAR-HEMATOTOX score available on line #CARTcells #lymsm https://t.co/H8CbH6cvhb https://t.co/zfET5Jcr6U
-
RT @OACerebro: ¿No le gusta leer artículos científicos o libros? Le recomiendo la aplicación: ♾️ https://t.co/h3Sq6xQgLU 1) Cargar el a…